- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 569
Carta to compete in corporate venturing
Carta Ventures will invest in startups developing technology of strategic interest to its parent, which is preparing for the launch of a trading platform later this year.
Feb 11, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020Snowflake falls for Salesforce in $479m round
Salesforce Ventures took part in a round that valued the cloud data analytics platform at $12.4bn, pushing its overall funding past $1.3bn.
Feb 10, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020HopSkipDrive picks up $22m
State Farm Ventures backed a round that will help HopSkipDrive expand across the US and add safety features to its children's ride-sharing service.
Feb 10, 2020Corporate venturing deal net: 3-7 February 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Feb 7, 2020Daily deal net: February 7, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 7, 2020Netskope catches $340m
The Dell-backed cloud security platform developer was valued at nearly $3bn in a late-stage round led by Sequoia Capital Global Equities.
Feb 7, 2020Lange lunges into PRF position
Wade Lange is Purdue Research Foundation's new vice-president and chief entrepreneurial officer, having previously served as Purdue Foundry's entrepreneur-in-residence.
Feb 7, 2020Schrödinger shakes out $202m from IPO
The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.
Feb 7, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


